Amylyx Pharmaceuticals
AMLX
#7300
Rank
ยฃ0.25 B
Marketcap
ยฃ3.76
Share price
-5.18%
Change (1 day)
-64.31%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2024 (TTM): ยฃ0.23 Billion

According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.23 Billion. In 2023 the company made a revenue of ยฃ0.29 Billion an increase over the revenue in the year 2022 that were of ยฃ18.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.23 B-20.13%
2023 ยฃ0.29 B1526.62%
2022 ยฃ18.37 M
2021 N/A